Weight loss · FAQ
Who should avoid GLP-1 medicines or other weight loss prescriptions?
Short answer
Weight loss medicines are not appropriate during pregnancy. Semaglutide and tirzepatide also have important restrictions, including a personal or family history of medullary thyroid cancer or MEN2. Other limits depend on the product. A licensed physician in your state must review your history before deciding whether treatment is appropriate.
Do not use weight loss medicine during pregnancy. Tell your physician if you are pregnant, breastfeeding, or planning pregnancy. Some medicines need to be stopped well before trying to conceive. The timing depends on the drug, so ask for a specific plan rather than stopping or restarting on your own.
Semaglutide and tirzepatide have warnings against use in people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, called MEN2. A prior serious allergic reaction to the prescribed drug is another reason not to use it. Severe stomach-emptying problems may also make these medicines unsuitable.
Tell your physician about pancreatitis, gallbladder disease, kidney problems, diabetes-related eye disease, and any eating disorder. These conditions require careful review, but not all are automatic exclusions. Oral weight kit restrictions depend on its ingredients and can differ from GLP-1 restrictions. A licensed physician in your state makes the final treatment decision after reviewing your individual risks.
Sources
Written by the Verra clinical team · Medical review pending
General information, not medical advice. If you're in crisis, call or text 988.